MSA - MULTIPLE SYSTEM ATROPHY
Clinical trials for MSA - MULTIPLE SYSTEM ATROPHY explained in plain language.
Never miss a new study
Get alerted when new MSA - MULTIPLE SYSTEM ATROPHY trials appear
Sign up with your email to follow new studies for MSA - MULTIPLE SYSTEM ATROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for MSA patients: drug targets dangerous blood pressure drops
Symptom relief OngoingThis study tests a drug called ampreloxetine in about 100 adults with multiple system atrophy (MSA) who have severe dizziness or fainting when standing due to low blood pressure. The goal is to see if the drug safely reduces these symptoms over 20 weeks. Participants first receiv…
Matched conditions: MSA - MULTIPLE SYSTEM ATROPHY
Phase: PHASE3 • Sponsor: Theravance Biopharma • Aim: Symptom relief
Last updated May 18, 2026 12:13 UTC
-
Nurse-Led video calls aim to ease daily life for rare parkinsonism patients
Symptom relief OngoingThis study tests whether regular video calls and health coaching from a specialized nurse can help people with atypical parkinsonism (like MSA or PSP) manage symptoms and avoid complications at home. 164 adults with these conditions will receive either standard care or extra tele…
Matched conditions: MSA - MULTIPLE SYSTEM ATROPHY
Phase: NA • Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Symptom relief
Last updated May 18, 2026 12:03 UTC
-
Mayo clinic launches major brain study to track disease progression
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to learn more about symptoms of brain diseases like Parkinson's and frontotemporal dementia. Researchers will track 500 adults over time using brain scans and genetic analysis to see how the disease changes. The goal is to better understand these conditions, not t…
Matched conditions: MSA - MULTIPLE SYSTEM ATROPHY
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 13, 2026 16:02 UTC